Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer.
Comput Struct Biotechnol J
; 17: 1020-1030, 2019.
Article
en En
| MEDLINE
| ID: mdl-31428295
APC, Antigen-Presenting Cell; BH, Benjami and Hochberg; Cancer genomics; DFS, Disease Free Survival; EMT, Epithelial-Mesenchymal Transition; FDR, False Discovery Rate; GSEA, Gene-Set Enrichment Analysis; HLA, Human Leukocyte Antigen; HNSCC, Head and Neck Squamous Cell Carcinomas; HPV, Human Papilloma Virus; HRAS mutations; Head and neck squamous cell carcinomas; MHC, Major Histocompatibility Complex; NK, Natural Killer; OR, Odds Ratio; OS, Overall Survival; TILs, Tumor-Infiltrating Lymphocytes; TIM, Tumor Immune Microenvironment; TMB, Tumor Mutation Burden; TP53 mutations; Tumor immunity; dMMR, Deficient Mismatch-Repair; pDCs, Plasmacytoid Dendritic Cells; ssGSEA, single-sample Gene-Set Enrichment Analysis
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Comput Struct Biotechnol J
Año:
2019
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
Países Bajos